Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis.
BACKGROUND
The critical mass hypothesis for atrial fibrillation (AF) was proposed in 1914. There has never been a systematic investigation defining the relationship between tissue geometry and AF. The purpose of this study was to determine the association among the probability of maintaining AF and the width, area, weight, effective refractory period (ERP), and wavelength in atrial tissue.


RESULTS
Isolated canine atria (n=20) were perfused with Krebs-Henseleit solution. Baseline ERPs were obtained with and without acetylcholine (10E-3.5 mol/L) using single extra-stimulus pacing while unipolar electrograms were recorded from 250 sites. The tissue was then partitioned using bipolar radiofrequency ablation, and the ERPs were measured again with and without acetylcholine. Any section of tissue that maintained AF was divided until the arrhythmia was no longer inducible. ERPs and conduction velocities were measured in all of the sections after each ablation, and the wavelengths were calculated. The probability of AF was found to be correlated with increasing tissue areas, widths, and weights (P<0.001). The probability of AF was significantly associated with the length of the ERP and the wavelength (P<0.001). With shorter ERPs and shorter wavelengths, there was an increased probability of sustained AF.


CONCLUSIONS
The probability of sustained AF was significantly associated with increasing tissue area, width, and weight and decreasing ERPs and wavelengths. These data may lead to a better understanding of the mechanism of AF and, thus, help to design more-effective interventional procedures in the future.
Byrd
Gregory D
GD
Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Prasad
Sandip M
SM
Ripplinger
Crystal M
CM
Cassilly
T Ryan
TR
Schuessler
Richard B
RB
Boineau
John P
JP
Damiano
Ralph J
RJ
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001281:Atrial Fibrillation / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery; D017115:Catheter Ablation; D004285:Dogs; D004562:Electrocardiography; D006325:Heart Atria / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D066298:In Vitro Techniques; D008955:Models, Cardiovascular; D009200:Myocardial Contraction / Q000502:physiology*; D009929:Organ Size; D012032:Refractory Period, Electrophysiological
D000109:Acetylcholine